Healthcare and Life Science
Arecor announces presentation at EASD 2022 of Phase I clinical trial of AT278 ultra-concentrated ultra-rapid acting insulin for diabetes
Arecor Therapeutics plc, a globally focused biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that its abstract titled “Phase I study investigating PK and PD of highly-concentrated insulin aspart AT278 U500” has been selected for presentation as ...
eg technology renew sponsorship of 2022 EIT Health Catapult
eg technology are pleased to announce they have renewed their sponsorship of the coveted EIT Health Catapult, in association with EIT Health. ...
Change Management doesn’t change the one thing you most need to change
High Performance Change says: If you wanted to drive across Australia, you’d pack the vehicle with a survival kit – to help you adapt to any situation you might find yourself in – before you departed. It would be utter madness to even think about just setting off as if it were a normal ...
Opportunities in China’s beauty value economy
What are the drivers for the phenomenal growth in China's hair care, anti-aging, and aesthetic medicine and cosmetic surgery markets? ...
LG Chem renews license triggering payment to Avacta
LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme ...
Charity Shop Manager shares her story
Arthur Rank Hospice Charity Shop Manager, Billie, shares her personal story ahead of the Chariots of Fire Repay Race in Cambridge 2022 ...
Avacta announces second dose escalation in the Phase I clinical study of AVA6000 Pro-doxorubicin
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the third dose...
Cambridge study shapes advice on brain surgery
A body dedicated improving outcomes for victims of traumatic brain injury has updated guidelines for clinicians following latest findings from a Cambridge-led trial. ...
Bio-Rad launches EconoFit Chromatography Column Packs
HERCULES, Calif.— Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification ...
Illumina invests in £30M venture fund to advance breakthroughs in human health
Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates. ...